Daily Anesthesiology Research Analysis
Three impactful anesthesiology/ICU studies stood out. A prospective physiological study used electrical impedance tomography to map regional airway opening pressure heterogeneity during low-flow insufflation, informing individualized PEEP titration. A nationwide cohort found hospital rapid response systems associated with lower 30- and 90-day postoperative mortality after general anesthesia. A population pharmacokinetic model of tranexamic acid in cardiopulmonary bypass supports precision dosing
Summary
Three impactful anesthesiology/ICU studies stood out. A prospective physiological study used electrical impedance tomography to map regional airway opening pressure heterogeneity during low-flow insufflation, informing individualized PEEP titration. A nationwide cohort found hospital rapid response systems associated with lower 30- and 90-day postoperative mortality after general anesthesia. A population pharmacokinetic model of tranexamic acid in cardiopulmonary bypass supports precision dosing based on body weight, renal function, and CPB effects.
Research Themes
- Ventilation physiology and bedside monitoring
- Perioperative safety systems and outcomes
- Precision pharmacology in cardiac anesthesia
Selected Articles
1. Distribution of airway pressure opening in the lungs measured with electrical impedance tomography (POET): a prospective physiological study.
In 36 mechanically ventilated AHRF patients, EIT during low-flow insufflation demonstrated heterogeneous, regional airway opening pressures; 25% showed elevated AOP, indicating airway closure above applied PEEP. The pressure-slope pattern during insufflation aligned with regional differences, supporting physiologic detection of airway closure distribution rather than a single global threshold.
Impact: This study operationalizes bedside EIT to map regional airway closure, challenging reliance on a single global AOP for PEEP titration and enabling individualized ventilation strategies.
Clinical Implications: Consider assessing regional airway closure when titrating PEEP in AHRF; patterns of low-flow pressure slope and EIT maps may help avoid under-recruitment or overdistension and personalize recruitment strategies.
Key Findings
- In 36 AHRF patients, EIT during low-flow insufflation revealed regional heterogeneity of airway opening.
- Approximately 25% (9/36) exhibited elevated airway opening pressure (AOP), implying airway closure above applied PEEP.
- Changes in the pressure slope during low-flow insufflation corresponded to regional AOP variations, enabling physiologic detection of heterogeneity.
Methodological Strengths
- Prospective physiological study with standardized low-flow insufflation maneuvers
- Use of electrical impedance tomography to provide regional, real-time lung ventilation mapping
Limitations
- Single-center study with a modest sample size (n=36)
- Physiologic endpoints without direct linkage to clinical outcomes
Future Directions: Test EIT-guided PEEP/recruitment protocols in randomized trials to assess impacts on oxygenation, ventilator-induced lung injury, and clinical outcomes.
BACKGROUND: In patients with acute hypoxemic respiratory failure (AHRF) under mechanical ventilation, the change in pressure slope during a low-flow insufflation indicates a global airway opening pressure (AOP) needed to reopen closed airways and may be used for titration of positive end-expiratory pressure. OBJECTIVES: To understand 1) if airways open homogeneously inside the lungs or significant regional AOP variations exist; 2) whether the pattern of the pressure slope change during low-flow insufflation can indicate the presence of regional AOP variations. METHODS: Using electrical impedance tomography, we
2. Association of rapid response system with clinical outcomes after surgery under general anesthesia.
In a nationwide propensity-matched cohort of 447,998 surgical patients per arm, hospital rapid response systems were associated with reduced 30-day mortality (OR 0.93), 90-day mortality (OR 0.94), and postoperative CPR events (OR 0.91) after general anesthesia. Findings support the broad perioperative safety value of RRS implementation.
Impact: With over 1.4 million cases analyzed, this study provides compelling real-world evidence that hospital RRSs improve postoperative outcomes at scale.
Clinical Implications: Investment in RRS teams and escalation protocols should be prioritized for postoperative wards to reduce mortality and in-hospital cardiac arrests after general anesthesia.
Key Findings
- Nationwide cohort of 1,416,844 surgical patients; PS-matched groups of 223,999 each for comparison.
- RRS implementation associated with lower 30-day mortality (OR 0.93, 95% CI 0.89–0.97) and 90-day mortality (OR 0.94, 95% CI 0.91–0.97).
- RRS hospitals had fewer CPR events postoperatively (OR 0.91, 95% CI 0.83–0.98).
Methodological Strengths
- Very large, population-based dataset with propensity score matching
- Multiple clinically meaningful endpoints (30- and 90-day mortality, CPR)
Limitations
- Observational design susceptible to residual confounding and unmeasured hospital-level differences
- No granular data on RRS structure, activation criteria, or response times
Future Directions: Investigate which RRS components (staffing, activation criteria, early warning integration) drive outcome improvements and evaluate cost-effectiveness.
BACKGROUND: In this population-based cohort study involving a nationwide database from South Korea, we aimed to determine whether rapid response system (RRS) implementation is associated with mortality and morbidity after surgery under general anesthesia. METHODS: Patients who underwent surgery under general anesthesia at the hospital between January 1, 2021, and December 31, 2021. Patients admitted to hospitals with an RRS were categorized into the RRS group, whereas those without an RRS were categorized into the non-RRS group. The endpoints were 30-day mortality, 90-day mortality, and CPR performance in the event of cardiac arrest. RESULTS: A total of 1,416,844 patients who underwent surgery under general anesthesia were included. The RRS and non-RRS groups included 512,911 and 903,933 patients, respectively. After propensity score (PS) matching, 447,998 patients were included in both groups (223,999 patients per group). In the PS-matched cohort, compared with the non-RRS group, the RRS group had 7 % (odds ratio [OR]: 0.93, 95 % confidence interval [CI]: 0.89, 0.97; P = 0.001), 6 % (OR: 0.94, 95 % CI: 0.91, 0.97; P < 0.001), and 9 % (OR: 0.91, 95 % CI: 0.83, 0.98; P = 0.020) lower incidences of 30-day mortality, 90-day mortality, and CPR, respectively. CONCLUSIONS: The RRS group had lower 30-day and 90-day mortality rates than the non-RRS group after surgery under general anesthesia. Moreover, RRS was associated with a lower rate of CPR episodes resulting from cardiac arrest in patients undergoing general anesthesia after surgery.
3. Population pharmacokinetic model of tranexamic acid in patients who undergo cardiac surgery with cardiopulmonary bypass.
In 77 cardiac surgery patients (453 samples), a two-compartment population PK model for tranexamic acid best fit the data, incorporating body weight and renal function as key covariates. Cardiopulmonary bypass was associated with reduced clearance, supporting dose adjustments during CPB to achieve target exposures while avoiding toxicity.
Impact: Provides a mechanistically informed PK framework to personalize tranexamic acid dosing during CPB, addressing variability and safety concerns (e.g., seizures) related to overexposure.
Clinical Implications: Consider dosing TXA using body weight and renal function, with reduced clearance during CPB; centers can implement model-informed dosing to balance antifibrinolytic efficacy and neurotoxicity risk.
Key Findings
- Prospective PK sampling (453 samples from 77 CPB patients) enabled robust model development.
- A two-compartment model with combined residual error best described TXA concentrations.
- Body weight and renal function were influential covariates; CPB was associated with reduced clearance, indicating the need for intraoperative dosing adjustment.
Methodological Strengths
- Prospective rich sampling with UPLC–MS/MS quantification
- Nonlinear mixed-effects modeling with covariate analysis (body weight, renal function)
Limitations
- Single-center sample of 77 patients may limit generalizability
- Model validation against clinical outcomes (bleeding, seizures) was not reported
Future Directions: Externally validate the model across centers, link exposure to efficacy/safety endpoints, and develop model-informed dosing tools for intraoperative use.
PURPOSE: Tranexamic acid (TXA) is widely used as an antifibrinolytic drug. However, studies to determine the optimal blood concentration of TXA have produced inconsistent results. During cardiac surgery, cardiopulmonary bypass (CPB) has serious effects on drug distribution, elimination, and plasma concentration. Therefore, we aimed to establish a population pharmacokinetics model of TXA in patients undergoing cardiac surgery with CPB that considers renal function as a covariate, thereby facilitating personalized treatment. METHODS: In total, 453 TXA plasma samples were prospectively collected from 77 patients who underwent cardiac surgery with CPB. Plasma concentrations were determined by ultra-performance liquid chromatography-tandem mass spectrometry. The population pharmacokinetic model of TXA was analyzed using nonlinear mixed-effects modeling. RESULTS: The two-compartment-based model with combined errors was determined as the best. The final model included the effect of bodyweight and CL CONCLUSION: Patients who undergo cardiac surgery with CPB may require an adjusted dose of TXA tailored to CPB due to lower CL